Handbook of Obesity, Two-Volume Set (eBook, PDF)

Redaktion: Bray, George A.; Bouchard, Claude

• Format: PDF

Produktbeschreibung

This 2 volume set comprises of the 4th edition of Volume 1 and the 5th edition of Volume 2. Volume 1 covers the basic science aspects under the broad topic areas of epidemiology, etiology, and pathophysiology of obesity. Volume 2 spotlights on clinical applications for evaluation, diagnosis, prevention, and treatment of obesity.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 1210
• Erscheinungstermin: 9. Januar 2024
• Englisch
• ISBN-13: 9781000960600
• Artikelnr.: 70215059

Autorenporträt

George A. Bray, MD, MACP, MACE, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Claude Bouchard, PhD, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States Peter T. Katzmarzyk, PhD, FACSM, FTOS, FAHA, Pennington Biomedical Research Center, Louisiana State University System, Baton Rouge, Louisiana, United States John P. Kirwan, PhD, Integrated Physiology and Molecular Medicine Laboratory, Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States Leanne M. Redman, PhD, Reproductive Endocrinology and Women's Health Laboratory, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, United States Philip R. Schauer, MD, Metamor Institute, Pennington Biomedical Research Center, Baton Rouge, Louisiana

Inhaltsangabe

Volume One Part 1 History, Definitions, and Prevalence Chapter 1 From
Hippocrates to the Obesity Society: A Brief History Chapter 2 Obesity in
Art and Literature Chapter 3 Measurement of Total Adiposity, Regional Fat
Depots, and Ectopic Fat Chapter 4 Anthropometric Indicators of Adiposity in
Relation to the Gold Standards Chapter 5 Worldwide and Regional Prevalence
of Obesity Chapter 6 Age, Sex, Ethnicity, and Other Sources of Variation in
the Prevalence of Obesity Part 2 Biological Determinants of Obesity Chapter
7 Bioenergetics and Obesity Chapter 8 Mitochondrial Metabolic
Inefficiencies in Skeletal Muscle: Implications for Obesity and Weight Loss
Chapter 9 Human Experimental Overfeeding Chapter 10 Biology of Calorie
Restriction and Intermittent Fasting Chapter 11 Genetic Epidemiology and
Obesity Chapter 12 Genetic Variation and Obesity Chapter 13 Single Gene
Defects and Obesity Chapter 14 Micro and Long RNAs as Regulators in Obesity
Chapter 15 Epigenetics and Obesity Chapter 16 The Role of Adipocyte
Precursors in Development and Obesity Chapter 17 Small Animal Models of
Obesity Chapter 18 Obesity in Nonhuman Primates Chapter 19 The
Transcriptome, Proteome, and Metabolome of Obesity Chapter 20 CNS
Regulation of Energy Balance Chapter 21 Gastrointestinal Regulation of
Energy Balance Chapter 22 Gut Microbiome and Obesity Chapter 23 Sympathetic
Nervous System and Obesity Chapter 24 Hypothalamic-Pituitary Hormones and
Obesity Chapter 25 Brown, Beige, and White Adipocyte Development Chapter 26
Adipose Tissue Metabolism, Adipokines, and Obesity Chapter 27 Hepatic,
Visceral, Pancreatic, and Cardiac Fat Deposition Chapter 28 Skeletal Muscle
Metabolism and Obesity Chapter 29 Resting Metabolic Rate, Thermic Effect of
Food, and Obesity Chapter 30 Energy Cost of Exercise, Postexercise
Metabolic Rates, and Obesity Chapter 31 Energy Partitioning, Substrate
Oxidation Rates, and Obesity Chapter 32 COVID-19, Other Microbial
Infections, and Obesity Part 3 Behavioral Determinants of Obesity Chapter
33 Obesity and Dietary Intake Chapter 34 Beverages and Obesity: A Review of
Current Scientific Evidence Chapter 35 Obesity and Sedentary Time at Work
and Home Chapter 36 Leisure Time Physical Activity and Obesity Chapter 37
Role of Early Life Nutrition & Breastfeeding on Obesity Development Chapter
38 Tobacco Use, Marijuana Use, Vaping, and Obesity Chapter 39 Sleep and
Obesity Chapter 40 Eating Disorders and Obesity Part 4 Environmental,
Social, and Cultural Determinants of Obesity Chapter 41 The Role of the
Food Industry in Obesity Chapter 42 Transportation Policies and Obesity
Chapter 43 Urban Environment and Obesity Chapter 44 Social and Economic
Factors Related to Obesity Across the Globe Chapter 45 Influence of Culture
on Obesity Chapter 46 Environmental Chemicals and Obesity Part 5
Consequences of Obesity Chapter 47 Obesity and Mortality Chapter 48 Obesity
and Heart Disease Chapter 49 Obesity and Hypertension Chapter 50 Obesity
and Lipoprotein Metabolism Chapter 51 Obesity and Insulin Resistance
Chapter 52 Obesity and Type 2 Diabetes Chapter 53 Obesity and Metabolic
Syndrome Chapter 54 Obesity and Cancer Chapter 55 Obesity and Inflammation
Chapter 56 Obesity, Gallbladder, and Gastrointestinal Diseases Chapter 57
Obesity and Liver Diseases Chapter 58 Obesity, Lung Function, and Lung
Disease Chapter 59 Obesity and Gout Chapter 60 Obesity, Osteoarthritis, and
Bone Disorders Chapter 61 Obesity and Cognitive Decline Chapter 62 Obesity,
Mental Health, and Health-related Quality of Life Chapter 63 Obesity and
Reproductive Dysfunction Chapter 64 Obesity in Pregnancy Complications and
Outcomes Chapter 65 Obesity, Growth, Development, Metabolic Disorder, and
Insulin Resistance in Pediatrics Chapter 66 Bias, Discrimination, and
Obesity Volume Two Part 1 Prevention and Economic Outcomes of Obesity
Chapter 1 Dietary Changes in Human Evolution: Implications for the
Prevention of Obesity Chapter 2 Evolutionary Changes in Physical Activity,
Diet, and Energy Expenditure: Implications for the Prevention of Obesity
Chapter 3 Prevention of Obesity in Adults Chapter 4 The Prevention of
Obesity in Children and Adolescents Chapter 5 Re-engineering the Built
Environment: Progress in Schools, Worksites, Neighborhoods, and Communities
Chapter 6 The Economic Costs of Obesity Chapter 7 Cost-effectiveness of
Obesity Prevention and Treatment Chapter 8 Role of Government and
Non-Government Organizations in the Obesity Pandemic and Its Prevention
Chapter 9 Role of Reimbursement in the Delivery of Treatment for Obesity in
Adults and Children Part 2 Evaluation of the Patients with Overweight or
Obesity Chapter 10 Classification, Evaluation, and Staging of the Patient
with Obesity Chapter 11 Indicators of Central Adiposity: A Critical
Evaluation of Their Usefulness Chapter 12 Genetic Obesity Syndromes Chapter
13 Ethnic and Racial Considerations in the Evaluation of the Patient with
Obesity Part 3 Lifestyle in the Management of Obesity: Behavioral
Modification, Diet, and Exercise Chapter 14 Best Practices: Obesity and the
Primary Care Providers Chapter 15 In-person Behavioral Approaches for
Weight Management Chapter 16 Behavioral Interventions Delivered Remotely
Chapter 17 Cultural Considerations in Behavioral Therapy for Management of
Obesity Chapter 18 Diet Composition and Weight Loss: Is a Calorie a
Calorie? Chapter 19 Circadian Rhythms and Weight Loss: Timed Food Intake
Chapter 20 Comparison of Modern-Millennial Diets Chapter 21 Dietary Energy
Density and Its Contribution to Weight Control Chapter 22 Dietary Patterns
as a Basis for Diet Selection Chapter 23 Physical Activity and Weight Loss:
Volume, Intensity, and Mode Chapter 24 Modifying Sedentary Behavior for the
Prevention and Treatment of Obesity Chapter 25 Preventing Weight Regain
After Weight Loss Chapter 26 Personalized and Precision Nutrition in the
Management of Obesity: Can We Tailor the Treatment to the Patient? Part 4
Medications in the Management of Obesity Chapter 27 Drug-associated Weight
Gain and Clinical Alternatives Chapter 28 Mechanisms of Drug Action in
Obesity Chapter 29 Metabolic Effects of Progressive Weight Loss Chapter 30
Older Drugs Used to Manage Obesity: Sympathomimetics and Orlistat Chapter
31 Serotonergic Drugs for Treating Obesity Chapter 32 Antidiabetic Drugs
that Reduce Weight and Are Cardioprotective Chapter 33 Approved Combination
Agents: Phentermine/Topiramate Chapter 34 Approved Combination Agents:
Naltrexone-Bupropion Chapter 35 Drugs That Affect Body Weight: The
Glucagon-like Peptide-1 Agonists Chapter 36 Hydrogels in the Treatment of
Obesity Chapter 37 Dual and Triple-Action Peptides Chapter 38 Antiobesity
Medications on the Horizon Chapter 39 Treatments for Rare Forms of Genetic
Obesity Chapter 40 Special Issues in Using Medications in Children &
Adolescents Chapter 41 Dietary Supplements and Weight Management Part 5
Surgical Interventions for Obesity Chapter 42 Historical Overview of
Metabolic and Bariatric Surgery Chapter 43 Overview: Current Metabolic
Operations and Long-term Outcomes Chapter 44 Effects of Metabolic Surgery
on Type 2 Diabetes Chapter 45 Cardiovascular Outcomes in Metabolic Surgery
Chapter 46 Effect of Bariatric Surgery on Cancer Chapter 47 Bariatric
Surgery in Pediatric Patients Chapter 48 Other Bariatric Procedures: Nerve
Stimulation, Gastric Balloons, Intestinal Liners, and Others